✦ LIBER ✦

Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer

✍ Scribed by Kabbinavar, F. F.

Book ID: 126749251
Publisher: American Society of Clinical Oncology
Year: 2005
Tongue: English
Weight: 257 KB
Volume: 23
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2005.00.232

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab Improves the Efficacy of 5-F

Bevacizumab Improves the Efficacy of 5-Fluorouracil/Leucovorin in Patients with Advanced Colorectal Cancer

✍ Nancy Price; Edward Chu; Vinay K. Jain 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 90 KB

Addition of Aflibercept to Fluorouracil,

Addition of Aflibercept to Fluorouracil, Leucovorin, and Irinotecan Improves Survival in a Phase III Randomized Trial in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen

✍ Van Cutsem, E.; Tabernero, J.; Lakomy, R.; Prenen, H.; Prausova, J.; Macarulla, 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 532 KB

Phase III Multicenter Randomized Clinica

Phase III Multicenter Randomized Clinical Trial to Evaluate the Safety and Efficacy of CoFactor®/5-Fluorouracil/Bevacizumab Versus Leucovorin/5-Fluorouracil/Bevacizumab as Initial Treatment for Metastatic Colorectal Carcinoma

✍ Muhammad Wasif Saif; James Merritt; Joan Robbins; Jeffrey Stewart; Joachim Schup 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 126 KB

Safety and efficacy of second-line treat

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer

✍ Xie, Song; Han, Guoping; Fan, Zhikun; He, Lifeng; Xu, Wenbing; Qin, Zhen 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 253 KB

A Phase II Study of ANGIOZYME® in combin

A Phase II Study of ANGIOZYME® in combination with 5-fluorouracil, leucovorin and ironotecan in the treatment of metastatic colorectal cancer patients

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Cost-effectiveness analysis of bevacizum

Cost-effectiveness analysis of bevacizumab combined with chemotherapy for the treatment of metastatic colorectal cancer in Japan

✍ Takeru Shiroiwa; Takashi Fukuda; Kiichiro Tsutani 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 238 KB